EPANOVA drug approval

Pfizer (NYSE: PFE) continues to pursue AstraZeneca plc (NYSE: AZN) despite three rejections this year and grave concern by U.K. politicians. History Of Bids On May 1, 2014, Bloomberg reported that Pfizer could raise its bid for AstraZeneca to more than $106 billion (63 billion pounds) and...